Redmile Group, LLC Sarepta Therapeutics, Inc. Transaction History

Redmile Group, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$117.53 - $155.99 $27.2 Million - $36.1 Million	231,595 New	231,595 $31.9 Million
Q3 2019 Nov 14, 2019	SELL	$72.81 - $156.91 $30 Million - $64.6 Million	-412,000 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$112.21 - $151.95 $46.2 Million - $62.6 Million	412,000 New	412,000 $62.6 Million
Q3 2018 Nov 14, 2018	SELL	$115.31 - $161.51 $3.59 Million - $5.02 Million	-31,100 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$71.74 - $153.69 $2.23 Million - $4.78 Million	31,100 New	31,100 $4.11 Million

526

84.4M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $9.97B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Redmile Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Redmile Group, LLC with notifications on news.